{"logo":"https://s3.polygon.io/logos/epix/logo.png","listdate":"1997-01-30","cik":"1633932","bloomberg":"EQ0000000041629241","figi":null,"lei":null,"sic":3741,"country":"can","industry":"Drug Manufacturers","sector":"Healthcare","marketcap":19207827,"employees":15,"phone":"+1 778 331-0962","ceo":"David R. Parkinson","url":"http://www.essapharmaceuticals.com","description":"ESSA Pharma Inc is a pharmaceutical company. The company is in preclinical stage, focused on the development of small molecule drugs for the treatment of castration-resistant prostate cancer.","exchange":"NASDAQ Capital Market","name":"ESSA Pharma Inc.","symbol":"EPIX","exchangeSymbol":"NSC","hq_address":"999 West Broadway Street Vancouver BC, V5Z 1K5","hq_state":"BC","hq_country":"CAN","type":"CS","updated":"11/16/2018","tags":["Healthcare","Drug Manufacturers - Specialty & Generic","Drug Manufacturers"],"similar":["XLV"],"active":true}